EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, TCRX: Tscan Therapeutics Inc

07 Nov 25 15:59
LAST:

1.070

CHANGE:
 0.07		OPEN:
1.130		HIGH:
1.160		ASK:
0.000		VOLUME:
656.3K
CHG(%):
6.03		PREV:
1.160		LOW:
1.070		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 251.1501.1601.0701.090727.7K
06 Nov 251.1101.1651.0801.160776.9K
05 Nov 251.1201.1601.0901.135821.8K
04 Nov 251.1701.2501.0801.1201.47M
03 Nov 251.4801.4801.1001.2405.25M
31 Oct 251.8601.9701.8451.940214.8K
30 Oct 251.9302.0151.7401.8601.24M
29 Oct 252.1402.1401.9101.920741.8K
28 Oct 252.2802.2812.1002.130602.8K
27 Oct 252.3702.4292.2502.280338.0K

COMPANY PROFILE

Name:Tscan Therapeutics Inc
About:TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:830 Winter Street, Waltham, MA, United States, 02451
Website:https://www.tscan.com
CUSIP:89854M101
CIK:0001783328
ISIN:US89854M1018
FIGI:BBG00PH1N007

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-1.09 
Forward P/E:-1.50 
PEG Ratio:-1.50 
Price to Sales:15.82 
Price to Book:0.62 
Operating Margin:-12.57 
Return on Assets:-0.27 
Return on Equity:-0.63 
EPS Ratio:-1.10 
Revenue:6.96M 
Shares:52.47M 
Market Cap:56.14M 

TECHNICAL INDICATORS

MA5:1.157.4%
MA10:1.5948.4%
MA20:1.9582.6%
MA50:1.9178.2%
MA100:1.8169.3%
MA200:1.7462.8%
RSI14:10.50 
WPR14:-100.00 
MTM14:-1.25
ROC14:-0.53 
ATR:0.21 
Week High:1.9784.1%
Week Low:1.070.0%
Month High:2.57140.2%
Month Low:1.0762.8%
Year High:6.23481.8%
Year Low:1.024.9%